Blockchain Registration Transaction Record

Glucotrack's Breakthrough in Diabetes Management: First-In-Human Study Success Fuels Ongoing Long-Term Trial

Glucotrack's CBGM system shows promise in diabetes management, with a successful first-in-human study leading to an upcoming OUS clinical trial. This breakthrough could revolutionize glucose monitoring for insulin-dependent patients, offering a more accurate and efficient solution for diabetes management.

This news highlights a significant advancement in diabetes care, offering hope for improved glucose monitoring for patients with insulin-dependent diabetes. The successful first-in-human study marks a crucial step towards bringing a potentially game-changing solution to market. The upcoming OUS clinical trial will further validate the CBGM system's durability, usability, and accuracy, potentially transforming how diabetes is managed in the future.